AudioPod
About this episode
Interventions designed to improve health, including targeted drugs and medical devices, typically undergo a complex and lengthy process of development. In a collaboration between the University of Wisconsin-Madison, Cornell University, the National Institutes of Health and Case Western Reserve University in the USA, experts Dr Clara Pelfrey, Dr Linda Scholl and colleagues have designed a case study protocol to improve understanding of this process.
Original Article Reference
This SciPod is a summary of the paper ‘A protocol for retrospective translational science case studies of health interventions’, from the Journal of Clinical and Translational Science. DOI: https://doi.org/10.1017/cts.2020.514.
This work is licensed under a Creative Commons Attribution 4.0 International License. 
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
Increase the impact of your research!
More episodes
Dr Fay Betsou | The Missing Piece in Medical Diagnostics: Why the Right Samples Matter
When a new medical test reaches a clinic or laboratory, most people focus on the technology itself. They think about...
Dr. Daniel Kroeger | Sleeping More Than Ever Before: The Surprising Science of Extra Sleep and Anxiety
For centuries, sleep has remained one of humanity’s greatest biological mysteries. We spend roughly a third of our...
Prof. Megan Lancaster | The Hidden Signals of the Heart: How Genetics Is Transforming the Fight Against Sudden Cardiac Death
The human heart beats with a rhythm so steady that most of us rarely stop to consider it. Each pulse carries oxygen,...
Prof. Jullie Pan | The Brain’s Hidden Chemistry: What the Hippocampus Reveals About Memory, Energy, and Disease
The human brain is often described as one of the most complex objects in the known universe. Yet even within this...
The Translational Asian Age-related Macular Degeneration Program Phase 2 (TAAP-2): Reimagining the Future of Vision Care
Age-related macular degeneration, often abbreviated as AMD, is one of the leading causes of vision loss among older...
Professor Saji George | When “Safe” Isn’t Safe Enough: What Hidden Fungal Toxins in Cannabis Could Mean for Public Health
Cannabis legalization in Canada was meant to bring transparency, consistency, and safety to a rapidly growing...